Erin McSweeney - UnitedHealth Group Executive Officer
| UNH Stock | USD 399.65 11.79 2.87% |
Executive
Erin McSweeney is Executive Officer of UnitedHealth Group Incorporated
| Age | 60 |
| Address | 1 Health Drive, Eden Prairie, MN, United States, 55344 |
| Phone | (800)-328-5979 |
| Web | https://www.unitedhealthgroup.com |
Latest Insider Transactions
UnitedHealth Group Management Efficiency
The company has Return on Asset of 0.0704 % which means that on every $100 spent on assets, it made $0.0704 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.227 %, implying that it generated $0.227 on every 100 dollars invested. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities. As of now, UnitedHealth Group's Return On Tangible Assets are increasing as compared to previous years. The UnitedHealth Group's current Return On Capital Employed is estimated to increase to 0.21, while Return On Equity is projected to decrease to 0.1. As of now, UnitedHealth Group's Total Current Assets are increasing as compared to previous years. The UnitedHealth Group's current Intangible Assets is estimated to increase to about 24.4 B, while Non Currrent Assets Other are projected to decrease to under 12.5 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Tilak Mandadi | CVS Health Corp | 61 | |
| Debra Bacon | Molina Healthcare | 57 | |
| Kyle Weber | Elevance Health | N/A | |
| Kate Goodrich | Humana Inc | N/A | |
| Gustavo Giraldo | CVS Health Corp | 52 | |
| Erin Champlin | Humana Inc | N/A | |
| Keith Wilson | Molina Healthcare | N/A | |
| Shannon Susko | Centene Corp | N/A | |
| David Reynolds | Molina Healthcare | N/A | |
| Brian MBA | Centene Corp | 65 | |
| Jamie Kates | Cigna Corp | 44 | |
| Vishal MD | Humana Inc | 51 | |
| John Kotal | Molina Healthcare | N/A | |
| Francis Clepper | Molina Healthcare | N/A | |
| Jennifer Vermeer | Molina Healthcare | N/A | |
| Udi Manber | Elevance Health | N/A | |
| Terese CPA | Cigna Corp | N/A | |
| Phil Austin | Cigna Corp | N/A | |
| David Falkowski | CVS Health Corp | N/A | |
| Hyong MD | Alignment Healthcare LLC | 55 | |
| Randall Fitzpatrick | Alignment Healthcare LLC | N/A | |
Management Performance
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0704 |
UnitedHealth Group Leadership Team
Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gail Wilensky, Independent Director | ||
| Richard Burke, Independent Chairman of the Board | ||
| Brian CPA, Chief UnitedHealthcare | ||
| Valerie Rice, Independent Director | ||
| Andrew Witty, Group President, Chief Executive Officer, Executive Vice President, Director | ||
| Terry Clark, Executive Officer | ||
| Sir Witty, CEO Director | ||
| Richard JD, Senior Officer | ||
| Stephen Hemsley, Non-Executive Chairman of the Board | ||
| John Rex, Chief Financial Officer, Executive Vice President | ||
| Dirk McMahon, President and Chief Operating Officer; Chief Executive Officer of UnitedHealthcare | ||
| Zachary Sopcak, Senior Relations | ||
| Erin McSweeney, Executive Officer | ||
| Matt Stearns, Senior President | ||
| Chris Zaetta, Chief VP | ||
| John Noseworthy, Independent Director | ||
| Jennifer Smoter, Senior Officer | ||
| William Ballard, Independent Director | ||
| Glenn Renwick, Independent Director | ||
| Rupert Bondy, Compliance Governance | ||
| Sandeep Dadlani, Executive Officer | ||
| Michele Hooper, Lead Independent Director | ||
| Timothy Flynn, Independent Director | ||
| Thomas Roos, Senior Vice President, Chief Accounting Officer | ||
| Richard MD, Executive Advisor | ||
| Matthew Friedrich, Executive Vice President Chief Legal Officer | ||
| MD MBA, Executive Innovation | ||
| Joy Fitzgerald, Equity Diversity | ||
| D Wilson, Executive Vice President - Human Capital | ||
| Jeff Putnam, Chief UnitedHealthcare | ||
| F McNabb, Independent Director | ||
| Paul Garcia, Independent Director | ||
| Heather Cianfrocco, Executive Optum | ||
| Marianne Short, Executive Vice President, Chief Legal Officer | ||
| Daniel Schumacher, Chief Officer | ||
| David Wichmann, Chief Executive Officer, Director | ||
| Patricia Lewis, Chief Human Resource Officer, Executive Vice President | ||
| Christopher Zaetta, Chief VP | ||
| Brian Thompson, Executive UnitedHealthcare | ||
| James Barry, Director Pennsylvania |
UnitedHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0704 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 429.04 B | ||||
| Shares Outstanding | 910.22 M | ||||
| Shares Owned By Insiders | 0.24 % | ||||
| Shares Owned By Institutions | 90.68 % | ||||
| Number Of Shares Shorted | 11.58 M | ||||
| Price To Earning | 26.34 X |
Currently Active Assets on Macroaxis
| AMT | American Tower Corp | |
| HLTOY | Hellenic Telecommunications Org | |
| NFLX | Netflix | |
| EPGFX | Europac Gold Fund | |
| FTGFF | Firan Technology Group |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.026 | Dividend Share 8.4 | Earnings Share 23.9 | Revenue Per Share | Quarterly Revenue Growth 0.098 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.